Back to CVE records
High 8.7HealthcarePublished Jul 8, 2026

CVE-2026-55471HAPI FHIR: XXE in XsltUtilities.saxonTransform via unhardened Saxon TransformerFactory

Updated under an hour ago ()

Does this affect you?

It affects hapifhir org.hl7.fhir.core and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.57%, higher than 46% of scored CVEs.

HAPI FHIR is a complete implementation of the HL7 FHIR standard for healthcare interoperability in Java. Prior to 6.9.10, org.hl7.fhir.utilities.XsltUtilities saxonTransform(...) overloads instantiated a bare net.sf.saxon.TransformerFactoryImpl() without ACCESS_EXTERNAL_DTD or ACCESS_EXTERNAL_STYLESHEET restrictions, allowing an attacker who controls or can tamper with transformed XML to trigger XML External Entity injection for local file disclosure and blind XXE or SSRF to arbitrary URLs reachable from the host. This issue is fixed in version 6.9.10.

CVSS
8.7 HIGH (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:L/SI:N/SA:N
Weakness (CWE)
CWE-611
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.57% (percentile 46)
Assigned by
GitHub_M
NVD analysis
Analyzed
Record last updated
Jul 9, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
hapifhir org.hl7.fhir.core
hapifhir:org.hl7.fhir.core (from the name)
before 6.9.10
CNA record
hapifhir hl7_fhir_core
hapifhir:hl7_fhir_core
before 6.9.10
NVD

References

  • x-refsource-confirm, exploit, third-party-advisory
  • x-refsource-misc, patch
  • x-refsource-misc, release-notes

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.